Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial.
Bartsch R, Berghoff AS, Furtner J, Marhold M, Bergen ES, Roider-Schur S, Starzer AM, Forstner H, Rottenmanner B, Dieckmann K, Bago-Horvath Z, Haslacher H, Widhalm G, Ilhan-Mutlu A, Minichsdorfer C, Fuereder T, Szekeres T, Oehler L, Gruenberger B, Singer CF, Weltermann A, Puhr R, Preusser M. Bartsch R, et al. Among authors: szekeres t. Nat Med. 2022 Sep;28(9):1840-1847. doi: 10.1038/s41591-022-01935-8. Epub 2022 Aug 8. Nat Med. 2022. PMID: 35941372 Free PMC article. Clinical Trial.
NT-proBNP in young healthy adults undergoing non-cardiac surgery.
Duma A, Maleczek M, Wagner C, Haslacher H, Szekeres T, Jaffe AS, Nagele P. Duma A, et al. Among authors: szekeres t. Clin Biochem. 2021 Oct;96:38-42. doi: 10.1016/j.clinbiochem.2021.07.009. Epub 2021 Jul 13. Clin Biochem. 2021. PMID: 34265286 Clinical Trial.
Epigallocatechin gallate, ellagic acid, and rosmarinic acid perturb dNTP pools and inhibit de novo DNA synthesis and proliferation of human HL-60 promyelocytic leukemia cells: Synergism with arabinofuranosylcytosine.
Saiko P, Steinmann MT, Schuster H, Graser G, Bressler S, Giessrigl B, Lackner A, Grusch M, Krupitza G, Bago-Horvath Z, Jaeger W, Fritzer-Szekeres M, Szekeres T. Saiko P, et al. Among authors: szekeres t. Phytomedicine. 2015 Jan 15;22(1):213-22. doi: 10.1016/j.phymed.2014.11.017. Epub 2014 Dec 3. Phytomedicine. 2015. PMID: 25636891
Pro- and anticarcinogenic mechanisms of piceatannol are activated dose dependently in MCF-7 breast cancer cells.
Vo NT, Madlener S, Bago-Horvath Z, Herbacek I, Stark N, Gridling M, Probst P, Giessrigl B, Bauer S, Vonach C, Saiko P, Grusch M, Szekeres T, Fritzer-Szekeres M, Jäger W, Krupitza G, Soleiman A. Vo NT, et al. Among authors: szekeres t. Carcinogenesis. 2010 Dec;31(12):2074-81. doi: 10.1093/carcin/bgp199. Epub 2009 Aug 20. Carcinogenesis. 2010. PMID: 19696164
5-FdUrd-araC heterodinucleoside re-establishes sensitivity in 5-FdUrd- and AraC-resistant MCF-7 breast cancer cells overexpressing ErbB2.
Strasser S, Maier S, Leisser C, Saiko P, Madlener S, Bader Y, Bernhaus A, Gueorguieva M, Richter S, Mader RM, Wesierska-Gadek J, Schott H, Szekeres T, Fritzer-Szekeres M, Krupitza G. Strasser S, et al. Among authors: szekeres t. Differentiation. 2006 Dec;74(9-10):488-98. doi: 10.1111/j.1432-0436.2006.00082.x. Differentiation. 2006. PMID: 17177846
Combination effects of digalloylresveratrol with arabinofuranosylcytosine and difluorodeoxycytidine in human leukemia and pancreatic cancer cells.
Saiko P, Graser G, Madlener S, Schwarz S, Krupitza G, Jaeger W, Somepalli V, Golakoti T, Fritzer-Szekeres M, Szekeres T. Saiko P, et al. Among authors: szekeres t. Nucleosides Nucleotides Nucleic Acids. 2011 Dec;30(12):1190-6. doi: 10.1080/15257770.2011.596497. Nucleosides Nucleotides Nucleic Acids. 2011. PMID: 22132974
Stilbene analogues affect cell cycle progression and apoptosis independently of each other in an MCF-7 array of clones with distinct genetic and chemoresistant backgrounds.
Bader Y, Madlener S, Strasser S, Maier S, Saiko P, Stark N, Popescu R, Huber D, Gollinger M, Erker T, Handler N, Szakmary A, Jäger W, Kopp B, Tentes I, Fritzer-Szekeres M, Krupitza G, Szekeres T. Bader Y, et al. Among authors: szekeres t. Oncol Rep. 2008 Mar;19(3):801-10. Oncol Rep. 2008. PMID: 18288419
Multifactorial anticancer effects of digalloyl-resveratrol encompass apoptosis, cell-cycle arrest, and inhibition of lymphendothelial gap formation in vitro.
Madlener S, Saiko P, Vonach C, Viola K, Huttary N, Stark N, Popescu R, Gridling M, Vo NT, Herbacek I, Davidovits A, Giessrigl B, Venkateswarlu S, Geleff S, Jäger W, Grusch M, Kerjaschki D, Mikulits W, Golakoti T, Fritzer-Szekeres M, Szekeres T, Krupitza G. Madlener S, et al. Among authors: szekeres t. Br J Cancer. 2010 Apr 27;102(9):1361-70. doi: 10.1038/sj.bjc.6605656. Br J Cancer. 2010. PMID: 20424615 Free PMC article.
204 results